(Q34804715)

4 August 2017

1 reference

title

Task force #1--magnitude of the prevention problem: opportunities and challenges. 33rd Bethesda Conference (English)

1 reference

4 August 2017

1

Emelia J Benjamin

0 references

Sidney C Smith

series ordinal

2

object named as

Sidney C Smith

1 reference

4 August 2017

Richard S Cooper

3

1 reference

4 August 2017

Martha N Hill

series ordinal

4

1 reference

4 August 2017

Russell V Luepker

series ordinal

5

1 reference

4 August 2017

language of work or name

English

0 references

publication date

1 August 2002

1 reference

Journal of the American College of Cardiology

4 August 2017

published in

1 reference

4 August 2017

volume

40

1 reference

4 August 2017

issue

4

1 reference

4 August 2017

page(s)

588-603

1 reference

Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California: demographic, physical, dietary and biochemical characteristics

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902082-X

7 January 2021

Prediction and possible prevention of coronary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902082-X

7 January 2021

Social/economic status and disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902082-X

7 January 2021

Trends and disparities in coronary heart disease, stroke, and other cardiovascular diseases in the United States: findings of the national conference on cardiovascular disease prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902082-X

7 January 2021

Social inequality, ethnicity and cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902082-X

7 January 2021

Neighborhood of residence and incidence of coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902082-X

7 January 2021

Recent trends in acute coronary heart disease--mortality, morbidity, medical care, and risk factors. The Minnesota Heart Survey Investigators.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902082-X

7 January 2021

Cardiovascular risk factor change--1973-74 to 1980-82: the Minnesota Heart Survey

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902082-X

7 January 2021

Mechanisms precipitating acute cardiac events: review and recommendations of an NHLBI workshop. National Heart, Lung, and Blood Institute. Mechanisms Precipitating Acute Cardiac Events Participants

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902082-X

7 January 2021

Estimation of contribution of changes in classic risk factors to trends in coronary-event rates across the WHO MONICA Project populations

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902082-X

7 January 2021

Risk factors for coronary heart disease among older men and women: a prospective study of community-dwelling elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902082-X

7 January 2021

Ethnic and socioeconomic differences in cardiovascular disease risk factors: findings for women from the Third National Health and Nutrition Examination Survey, 1988-1994

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902082-X

7 January 2021

Trends in the Prevalence, Awareness, Treatment, and Control of Hypertension in the Adult US Population : Data From the Health Examination Surveys, 1960 to 1991

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902082-X

7 January 2021

Declining serum total cholesterol levels among US adults. The National Health and Nutrition Examination Surveys.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902082-X

7 January 2021

Prevalence of Hypertension in the US Adult Population : Results From the Third National Health and Nutrition Examination Survey, 1988-1991

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902082-X

7 January 2021

Secular trends in blood pressure levels in Denmark 1964-1991.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902082-X

7 January 2021

Overweight and obesity in the United States: prevalence and trends, 1960-1994

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902082-X

7 January 2021

Diabetes and cardiovascular disease. The Framingham study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902082-X

7 January 2021

Impact of high-normal blood pressure on the risk of cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902082-X

7 January 2021

Low risk-factor profile and long-term cardiovascular and noncardiovascular mortality and life expectancy: findings for 5 large cohorts of young adult and middle-aged men and women

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902082-X

7 January 2021

Primary prevention of coronary heart disease in women through diet and lifestyle

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902082-X

7 January 2021

Optimal risk factors in the population: prognosis, prevalence, and secular trends; data from Göteborg population studies

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902082-X

7 January 2021

Cardiovascular mortality in hypertensive men according to presence of associated risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902082-X

7 January 2021

Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902082-X

7 January 2021

Diet, lifestyle, and the risk of type 2 diabetes mellitus in women

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902082-X

7 January 2021

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902082-X

7 January 2021

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902082-X

7 January 2021

Cardiovascular Health in Childhood: A Statement for Health Professionals From the Committee on Atherosclerosis, Hypertension, and Obesity in the Young (AHOY) of the Council on Cardiovascular Disease in the Young, American Heart Association

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902082-X

7 January 2021

Long-term effects of neonatal sodium restriction on blood pressure.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902082-X

7 January 2021

Guide to primary prevention of cardiovascular diseases. A statement for healthcare professionals from the Task Force on Risk Reduction. American Heart Association Science Advisory and Coordinating Committee

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902082-X

7 January 2021

AHA Conference Proceedings. Prevention conference V: Beyond secondary prevention: Identifying the high-risk patient for primary prevention: executive summary. American Heart Association

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902082-X

7 January 2021

Cardiovascular protection and blood pressure reduction: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902082-X

7 January 2021

Effect of HMGcoA reductase inhibitors on stroke. A meta-analysis of randomized, controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902082-X

7 January 2021

Effect of statins on risk of coronary disease: a meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902082-X

7 January 2021

Physical fitness and activity as separate heart disease risk factors: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902082-X

7 January 2021

Cost-effectiveness analysis of intensive blood-glucose control with metformin in overweight patients with type II diabetes (UKPDS No. 51).

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902082-X

7 January 2021

Lifetime health and economic benefits of weight loss among obese persons

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902082-X

7 January 2021

Use and cost effectiveness of smoking-cessation services under four insurance plans in a health maintenance organization.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902082-X

7 January 2021

27th Bethesda Conference: matching the intensity of risk factor management with the hazard for coronary disease events. Task Force 8. Organization of preventive cardiology service

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902082-X

7 January 2021

Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902082-X

7 January 2021

Clustering of metabolic factors and coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902082-X

7 January 2021

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902082-X

7 January 2021

Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902082-X

7 January 2021

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902082-X

7 January 2021

Influence on prognosis and morbidity of left ventricular ejection fraction with and without signs of left ventricular failure after acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902082-X

7 January 2021

AHA/ACC guidelines for preventing heart attack and death in patients with atherosclerotic cardiovascular disease: 2001 update

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902082-X

7 January 2021

ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902082-X

7 January 2021

Risk-reduction therapy: the challenge to change. Presented at the 68th scientific sessions of the American Heart Association November 13, 1995 Anaheim, California

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902082-X

7 January 2021

Quality of care for Medicare patients with acute myocardial infarction. A four-state pilot study from the Cooperative Cardiovascular Project

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902082-X

7 January 2021

Analysis of the degree of undertreatment of hyperlipidemia and congestive heart failure secondary to coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902082-X

7 January 2021

Use of lipid-lowering medications at discharge in patients with acute myocardial infarction: data from the National Registry of Myocardial Infarction 3.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902082-X

7 January 2021

Ineffective secondary prevention in survivors of cardiovascular events in the US population: report from the Third National Health and Nutrition Examination Survey

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902082-X

7 January 2021

National Survey on Gender Differences in Cardiac Rehabilitation Programs. Patient characteristics and enrollment patterns.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902082-X

7 January 2021

Improved treatment of coronary heart disease by implementation of a Cardiac Hospitalization Atherosclerosis Management Program (CHAMP)

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902082-X

7 January 2021

Improving the quality of care for Medicare patients with acute myocardial infarction: results from the Cooperative Cardiovascular Project

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902082-X

7 January 2021

Health and economic benefits of increased beta-blocker use following myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902082-X

7 January 2021

Cost effectiveness of ramipril treatment for cardiovascular risk reduction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902082-X

7 January 2021

Decline in mortality from coronary heart disease in Finland from 1969 to 1979.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902082-X

7 January 2021

Joint analysis of three U.S. community intervention trials for reduction of cardiovascular disease risk.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902082-X

7 January 2021

Community education for cardiovascular disease prevention. Morbidity and mortality results from the Minnesota Heart Health Program

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902082-X

7 January 2021

Effects of a community-wide health education program on cardiovascular disease morbidity and mortality: the Stanford Five-City Project

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902082-X

7 January 2021

Community education for cardiovascular disease prevention: risk factor changes in the Minnesota Heart Health Program

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902082-X

7 January 2021

The Pawtucket Heart Health Program: community changes in cardiovascular risk factors and projected disease risk

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902082-X

7 January 2021

Prevalence and social correlates of cardiovascular disease risk factors in Harlem

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902082-X

7 January 2021

Linking community-based blood pressure measurement to clinical care: a randomized controlled trial of outreach and tracking by community health workers

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902082-X

7 January 2021

A clinic and community-based approach to hypertension control for an underserved minority population: design and methods

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902082-X

7 January 2021

The determinants of hypertension awareness, treatment, and control in an insured population

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902082-X

7 January 2021

Barriers to blood pressure control

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902082-X

7 January 2021

Review of community-based research: assessing partnership approaches to improve public health

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902082-X

7 January 2021

Race and the response to adrenergic blockade with carvedilol in patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902082-X

7 January 2021

The effect of patient race and socio-economic status on physicians' perceptions of patients

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902082-X

7 January 2021

Behavior and biology: the basic sciences for AHA action: presented at the 70th scientific sessions of the American Heart Association, November 9, 1997, Orlando, Florida

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902082-X

7 January 2021

Barriers to hypertension care and control

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902082-X

7 January 2021

Inadequate Management of Blood Pressure in a Hypertensive Population

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902082-X

7 January 2021

Why don't physicians follow clinical practice guidelines? A framework for improvement

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902082-X

7 January 2021

The therapeutic gap--compliance with medication and guidelines

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902082-X

7 January 2021

Lifestyle changes after a myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902082-X

7 January 2021

Integrated approaches to management of hypertension: promoting treatment acceptance

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902082-X

7 January 2021

Overcoming barriers to preventive care

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902082-X

7 January 2021

Reviews of evidence regarding interventions to reduce tobacco use and exposure to environmental tobacco smoke

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902082-X

7 January 2021

Practice guidelines developed by specialty societies: the need for a critical appraisal

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902082-X

7 January 2021

Self-reported hypertension treatment practices among primary care physicians: blood pressure thresholds, drug choices, and the role of guidelines and evidence-based medicine

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902082-X

7 January 2021

The essence of effective treatment and compliance is simplicity

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902082-X

7 January 2021

Indications for cholesterol-lowering medication: comparison of risk-assessment methods

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902082-X

7 January 2021

Guidelines on preventing cardiovascular disease in clinical practice

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902082-X

7 January 2021

Improving quality of care for acute myocardial infarction: The Guidelines Applied in Practice (GAP) Initiative

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902082-X

7 January 2021

Communication skills for preventive interventions

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902082-X

7 January 2021

The multilevel compliance challenge: recommendations for a call to action. A statement for healthcare professionals.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902082-X

7 January 2021

A critical review of interventions to increase compliance with medication-taking, obtaining medication refills, and appointment-keeping in the treatment of cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902082-X

7 January 2021

Prediction of Coronary Heart Disease Using Risk Factor Categories

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902082-X

7 January 2021

Guidelines for clinical guidelines

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902082-X

7 January 2021

A simple computer program for guiding management of cardiovascular risk factors and prescribing

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902082-X

7 January 2021

A means to an end: an overview of a hyperlipidemia outcomes management program

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902082-X

7 January 2021

Put prevention into practice. Evaluation of program initiation in nine Texas clinical sites.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902082-X

7 January 2021

Improving patient outcomes by pooling resources (the Texas Heart Care Partnership experience)

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902082-X

7 January 2021

Heart disease education and prevention program targeting immigrant Latinos: using focus group responses to develop effective interventions

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902082-X

7 January 2021

Effects of computer-based clinical decision support systems on physician performance and patient outcomes: a systematic review.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902082-X

7 January 2021

Critical pathways : a review. Committee on Acute Cardiac Care, Council on Clinical Cardiology, American Heart Association

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902082-X

7 January 2021

Team management of patients with heart failure: A statement for healthcare professionals from The Cardiovascular Nursing Council of the American Heart Association

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902082-X

7 January 2021

Organizational interventions to encourage guideline implementation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902082-X

7 January 2021

Which is more important for the efficiency of hypertension treatment: hypertension stage, type of drug or therapeutic compliance?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902082-X

7 January 2021

Social marketing: application to medical education.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902082-X

7 January 2021

10.1016/S0735-1097(02)02082-X

Identifiers

DOI

1 reference

4 August 2017

1 reference